Tag: Biotechnology Research

Aviceda Therapeutics Appoints Dr. Jeffrey Nau as Chief Executive Officer
United States

Aviceda Therapeutics Appoints Dr. Jeffrey Nau as Chief Executive Officer

Press Release – CAMBRIDGE, Mass. – Aviceda Therapeutics (“Aviceda”), a private, clinical-stage biotech company focused on developing next-generation immunomodulators incorporating its proprietary High Affinity Ligands of Siglecs (HALOS™) nanotechnology platform with an aim to alleviate chronic, non-resolving inflammation, today announced the appointment of Jeffrey Nau, Ph.D., M.M.S., as Chief Executive Officer (CEO), effective immediately. Dr. Nau will also join the Aviceda Board of Directors. Dr. Nau … Continue reading Aviceda Therapeutics Appoints Dr. Jeffrey Nau as Chief Executive Officer

Impact Newswire
Variational AI Announces Oversubscribed $5.5 Million
Global

Variational AI Announces Oversubscribed $5.5 Million Financing to Launch Foundation Model for Small Molecule Drug Discovery

New funding to fuel market expansion of compute efficient foundation model for biopharmaceutical companies Press Release – February 20, 2025 – VANCOUVER, British Columbia – Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, today announced the completion of its oversubscribed $US5.5 million Seed extension round. Enki™ empowers biopharmaceutical chemistry teams to efficiently discover and optimize novel hits and … Continue reading Variational AI Announces Oversubscribed $5.5 Million Financing to Launch Foundation Model for Small Molecule Drug Discovery

Impact Newswire
Atomwise Appoints Steve Worland, Ph.D. as Chief Executive Officer
United States

Atomwise Appoints Steve Worland, Ph.D. as Chief Executive Officer

Proven Pharmaceutical Executive Brings Over 30 Years of R&D Experience to Supercharge the Company’s Next Phase of Growth Seasoned Biotechnology Leader Mike Varney, Ph. D., Appointed as Lead Independent Director of the Board Press Release – SAN FRANCISCO, CALIFORNIA, FEBRUARY 18, 2025 – Atomwise, a leader in leveraging machine learning and artificial intelligence (ML/AI) to advance small molecule drug discovery, today announced the appointment of Steve … Continue reading Atomwise Appoints Steve Worland, Ph.D. as Chief Executive Officer

Impact Newswire
Syngenta and TraitSeq
Europe

Artificial intelligence is speeding up the development of the next generation of biostimulants

Syngenta Crop Protection and TraitSeq announce a pioneering collaboration which could help farmers transition to more sustainable practices. Press Release – January 09, 2025 – BASEL, Switzerland & NORWICH, England – Syngenta and the pioneering artificial intelligence (AI) company TraitSeq are combining forces to use the full power of AI for the development of innovative, high-performance biostimulants. Syngenta, a world leader in developing the next … Continue reading Artificial intelligence is speeding up the development of the next generation of biostimulants

Impact Newswire
IDRx
Untied Kingdom

GSK Enters Agreement to Acquire IDRx, Inc.

Press Release – January 13, 2025 – PLYMOUTH, Mass. – GSK plc (LSE/NYSE: GSK) and IDRx, Inc. (IDRx) today announced that they have entered into an agreement under which GSK will acquire IDRx, a Boston-based, clinical-stage biopharmaceutical company dedicated to developing precision therapeutics for the treatment of GIST. Under the agreement, GSK will pay $1 billion upfront, with potential for an additional $150 million success-based … Continue reading GSK Enters Agreement to Acquire IDRx, Inc.

Impact Newswire
BIOTECANADA
Global

BIOTECanada Welcomes New President & CEO

Press Release – January 10, 2025 – OTTAWA, Ontario – On behalf of the Board of Directors of BIOTECanada, Chairman Oliver Technow is pleased to announce the appointment of Wendy Zatylny as the incoming President & CEO of BIOTECanada, representing the biotechnology ecosystem in Canada. “Her experience in leading a national industry association equips her with valuable insights and expertise that will drive BIOTECanada’s ongoing … Continue reading BIOTECanada Welcomes New President & CEO

Impact Newswire
Enveda
United States

Enveda Welcomes Jason Kim as Chief Financial Officer

Press Release – January 10, 2025 – BOULDER, Colo. – Enveda, a biotechnology company using AI to translate life’s chemistry into new medicines, today announced the appointment of Jason Kim as Chief Financial Officer (CFO). Mr. Kim brings more than 20 years of biopharmaceutical corporate development and financial leadership experience to the Enveda team. “His proven track record of driving financial and operational success in … Continue reading Enveda Welcomes Jason Kim as Chief Financial Officer

Impact Newswire
Tango Biosciences
United States

Michael Scholle Appointed CEO of Tango Biosciences

Co-founder Brian Kay to assume Chief Scientific Officer, focused on scientific innovation and operations Press Release – January 07, 2025 – CHICAGO – Tango Biosciences, Inc., the premier research partner for custom affinity reagents by phage display, announced Michael Scholle, MS, MBA as Chief Executive Officer effective immediately. Scholle is one of three co-founders of Tango Biosciences and an active board member. This transition enables president and … Continue reading Michael Scholle Appointed CEO of Tango Biosciences

Impact Newswire
City Therapeutics, Inc.
United States

City Therapeutics Appoints Andy Orth as Chief Executive Officer

Orth brings more than 25 years of global industry experience to CEO role, with strong track record in corporate and commercial strategy City co-founder Dr. John Maraganore to retain active executive chair role to ensure company leads next-generation RNAi therapeutics CAMBRIDGE, Mass – City Therapeutics, Inc., a biopharmaceutical company leading the future of RNA interference (RNAi)-based medicine, today announced the appointment of Andrew “Andy” Orth … Continue reading City Therapeutics Appoints Andy Orth as Chief Executive Officer

Impact Newswire